Market Overview:
The global acne therapeutics market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of acne, rising awareness about available treatment options, and growing demand for better-tolerated therapies. The global acne therapeutics market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical medication and oral medication. Topical medications are further sub-segmented into antibiotics, retinoids/retinoid analogs/derivatives), benzoyl peroxide preparations), hormonal agents (including spironolactone) salicylic acid preparations) Others ( including azelaic acid). Oral medications are further sub-segmented into systemic antibiotics isotretinoin dapsone erythromycin tetracycline minocycline doxycycline sulfacetamide sodium clindamycin phosphate). On the basis of application, the market is segmented into inflammatory acne and noninflammatory acne. Inflammatory acne is further sub-segmented into papules pustules nodules cysts while noninflammatory acnes include blackheads whiteheads comedones seborrhea erythema etc.).
Product Definition:
Topical Medication:
Topical medication is the term used to define drugs that are applied to the skin. Topical medications include OTC drugs, prescription medicines, and over-the-counter (OTC) medicines. The factors that propel topical medication growth in acne therapeutics market include rising prevalence of acne and other skin disorders coupled with increasing awareness about various treatment options available for acne such as topical medications among patients.
Oral Medication:
Oral medications are drugs that are taken in the mouth. They may be prescribed by a doctor or purchased over-the-counter (OTC). Most of the time, they come in tablet or capsule form and must be consumed orally. Some medications may also be administered via injection, but this is rare and usually for patients who cannot take tablets/capsules or who are at risk of developing drug resistance.
Application Insights:
The inflammatory acne segment held the largest share of over 70.0% in 2017. Inflammatory acne is characterized by redness, pain and swelling at the site of acne lesions and occurs most often on the face, chest and back. It is a severe form of acne which requires urgent treatment as it can spread to other parts of the body leading to serious complications.
Non-inflammatory or comedonalacne also known as blackheadsand whiteheads are common types ofacne that occur mostly onthe skinofthehead,faceand neck area. They generallydo not require any medicaltreatment however; they may leadto moreserious formsofacnereither temporary or permanent depending upon its severity.- Temporary non-inflammatory or ComedonalAcne: This type usually goes away by itself within 1 to 6 months without any intervention but if it persists for longer then regular checkups with a dermatologist are required.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing consumer awareness, high disposable income, and availability of effective treatment methods in this region. Moreover, higher adoption of new technologies and a large number of R&D activities are also expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness significant growth during the forecast period owing to rising disposable income levels and improving healthcare infrastructure in emerging countries such as China & India. In addition, an increase in spending on medical treatments is also likely to contribute towards industry growth during the same period. Furthermore, growing product demand for acne treatment from these regions coupled with government support for R&D activities will further propel industry expansion over next few years (read more).
Growth Factors:
- Increasing incidence of acne across all age groups
- Growing awareness about the available treatment options for acne
- Rising demand for effective and safe acne therapies
- Proliferation of online platforms providing information on acne treatments
- increasing investment in research and development of new drugs to treat acne
Scope Of The Report
Report Attributes
Report Details
Report Title
Acne Therapeutics Market Research Report
By Type
Topical Medication, Oral Medication
By Application
Inflammatory Acne, Non-inflammatory Acne
By Companies
GlaxoSmithKline, Pfizer, Johnson & Johnson, Roche, Teva Pharmaceutical, Bayer, Mylan, Allergan, Bausch Health, Nestle (Galderma), Cipher Pharmaceuticals, Sun Pharmaceutical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
223
Number of Tables & Figures
157
Customization Available
Yes, the report can be customized as per your need.
Global Acne Therapeutics Market Report Segments:
The global Acne Therapeutics market is segmented on the basis of:
Types
Topical Medication, Oral Medication
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Inflammatory Acne, Non-inflammatory Acne
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- Pfizer
- Johnson & Johnson
- Roche
- Teva Pharmaceutical
- Bayer
- Mylan
- Allergan
- Bausch Health
- Nestle (Galderma)
- Cipher Pharmaceuticals
- Sun Pharmaceutical
Highlights of The Acne Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Medication
- Oral Medication
- By Application:
- Inflammatory Acne
- Non-inflammatory Acne
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Acne Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Acne Therapeutics is a biotechnology company focused on the development of novel therapeutics for acne. The company's lead product candidate, AC-11, is an investigational topical agent that is in Phase III clinical trials for the treatment of moderate to severe acne.
Some of the major players in the acne therapeutics market are GlaxoSmithKline, Pfizer, Johnson & Johnson, Roche, Teva Pharmaceutical, Bayer, Mylan, Allergan, Bausch Health, Nestle (Galderma), Cipher Pharmaceuticals, Sun Pharmaceutical.
The acne therapeutics market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Acne Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Acne Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Acne Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Acne Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Acne Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Acne Therapeutics Market Size and Y-o-Y Growth
4.5.2 Acne Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Topical Medication
5.2.2 Oral Medication
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Inflammatory Acne
6.2.2 Non-inflammatory Acne
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Acne Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Acne Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Topical Medication
9.6.2 Oral Medication
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Inflammatory Acne
9.10.2 Non-inflammatory Acne
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Topical Medication
10.6.2 Oral Medication
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Inflammatory Acne
10.10.2 Non-inflammatory Acne
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Topical Medication
11.6.2 Oral Medication
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Inflammatory Acne
11.10.2 Non-inflammatory Acne
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Topical Medication
12.6.2 Oral Medication
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Inflammatory Acne
12.10.2 Non-inflammatory Acne
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Topical Medication
13.6.2 Oral Medication
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Inflammatory Acne
13.10.2 Non-inflammatory Acne
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Acne Therapeutics Market: Competitive Dashboard
14.2 Global Acne Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 GlaxoSmithKline
14.3.2 Pfizer
14.3.3 Johnson & Johnson
14.3.4 Roche
14.3.5 Teva Pharmaceutical
14.3.6 Bayer
14.3.7 Mylan
14.3.8 Allergan
14.3.9 Bausch Health
14.3.10 Nestle (Galderma)
14.3.11 Cipher Pharmaceuticals
14.3.12 Sun Pharmaceutical
